Silverback Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.4M | 335k | 10.05 |
| 2025-06-30 | $5.7M | 326k | 17.45 |
| 2025-03-31 | $3.5M | 280k | 12.58 |
| 2024-12-31 | $2.6M | 247k | 10.55 |
| 2024-09-30 | $3.4M | 235k | 14.50 |
| 2024-06-30 | $231k | 27k | 8.51 |
| 2024-03-31 | $132k | 13k | 10.22 |
| 2023-12-31 | $71k | 13k | 5.48 |
| 2023-09-30 | $49k | 13k | 3.78 |
| 2020-12-31 | $2.7M | 58k | 46.34 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas